Digol, Prince Aj A.
HRN: 27-18-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CEFTRIAXONE 1G (VIAL)
06/19/2026
06/25/2026
IV
1.2g
Q12
CNSI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: